APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neutropenia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neutropenia Drugs Industry Growth and Trends Forecast to 2032

26 December 2025106 pages

Choose your research edition.

Industry ResearchNeutropenia Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Neutropenia Drugs Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Neutropenia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neutropenia Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Neutropenia Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Neutropenia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neutropenia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neutropenia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neutropenia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neutropenia Drugs include Apotex Inc., Biogenomics Limited, Cellerant Therapeutics, Inc., Coherus BioSciences, Inc., Dr. Reddy’s Laboratories Limited, Ligand Pharmaceuticals, Inc., NAL Pharmaceuticals Ltd., Prolong Pharmaceuticals, LLC and Richter Gedeon Nyrt., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neutropenia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neutropenia Drugs market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neutropenia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neutropenia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neutropenia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neutropenia Drugs Market by Company

Apotex Inc.

Biogenomics Limited

Cellerant Therapeutics, Inc.

Coherus BioSciences, Inc.

Dr. Reddy’s Laboratories Limited

Ligand Pharmaceuticals, Inc.

NAL Pharmaceuticals Ltd.

Prolong Pharmaceuticals, LLC

Richter Gedeon Nyrt.

Sandoz International GmbH

Neutropenia Drugs Segment by Type

Capsule

Injection

Neutropenia Drugs Segment by Application

Hospital

Clinic

Neutropenia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neutropenia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neutropenia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neutropenia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neutropenia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neutropenia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Injection Table 3. Global Neutropenia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Neutropenia Drugs Sales by Type (2021-2026) & (Tons) Table 5. Global Neutropenia Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Neutropenia Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Neutropenia Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Neutropenia Drugs Price by Type (2021-2026) & (US$/Ton) Table 9. Global Neutropenia Drugs Sales by Type (2027-2032) & (Tons) Table 10. Global Neutropenia Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Neutropenia Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Neutropenia Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Neutropenia Drugs Price by Type (2027-2032) & (US$/Ton) Table 14. North America Neutropenia Drugs Sales by Type (2021-2026) & (Tons) Table 15. North America Neutropenia Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Neutropenia Drugs Sales by Type (2021-2026) & (Tons) Table 17. Europe Neutropenia Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Neutropenia Drugs Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Neutropenia Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Neutropenia Drugs Sales by Type (2021-2026) & (Tons) Table 21. Latin America Neutropenia Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Neutropenia Drugs Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Neutropenia Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Neutropenia Drugs Industry Trends Table 25. Neutropenia Drugs Industry Drivers Table 26. Neutropenia Drugs Industry Opportunities and Challenges Table 27. Neutropenia Drugs Industry Restraints Table 28. Global Neutropenia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Neutropenia Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Neutropenia Drugs Sales by Company (2021-2026) & (Tons) Table 31. Global Neutropenia Drugs Sales Share by Company (2021-2026) Table 32. Global Neutropenia Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Neutropenia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Neutropenia Drugs Major Company Production Sites and Headquarters Table 35. Global Neutropenia Drugs Company, Product Type & Application Table 36. Global Neutropenia Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Neutropenia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Neutropenia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Neutropenia Drugs Sales by Region (2021-2026) & (Tons) Table 41. Global Neutropenia Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Neutropenia Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Neutropenia Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Neutropenia Drugs Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Neutropenia Drugs Sales by Region (2027-2032) & (Tons) Table 46. Global Neutropenia Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Neutropenia Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Neutropenia Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Neutropenia Drugs Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Neutropenia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Neutropenia Drugs Sales by Application (2021-2026) & (Tons) Table 52. Global Neutropenia Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Neutropenia Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Neutropenia Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Neutropenia Drugs Price by Application (2021-2026) & (US$/Ton) Table 56. Global Neutropenia Drugs Sales by Application (2027-2032) & (Tons) Table 57. Global Neutropenia Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Neutropenia Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Neutropenia Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Neutropenia Drugs Price by Application (2027-2032) & (US$/Ton) Table 61. North America Neutropenia Drugs Sales by Application (2021-2026) & (Tons) Table 62. North America Neutropenia Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Neutropenia Drugs Sales by Application (2021-2026) & (Tons) Table 64. Europe Neutropenia Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Neutropenia Drugs Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Neutropenia Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Neutropenia Drugs Sales by Application (2021-2026) & (Tons) Table 68. Latin America Neutropenia Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Neutropenia Drugs Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Neutropenia Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Apotex Inc. Company Information Table 72. Apotex Inc. Business Overview Table 73. Apotex Inc. Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Apotex Inc. Neutropenia Drugs Product Portfolio Table 75. Apotex Inc. Recent Development Table 76. Biogenomics Limited Company Information Table 77. Biogenomics Limited Business Overview Table 78. Biogenomics Limited Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Biogenomics Limited Neutropenia Drugs Product Portfolio Table 80. Biogenomics Limited Recent Development Table 81. Cellerant Therapeutics, Inc. Company Information Table 82. Cellerant Therapeutics, Inc. Business Overview Table 83. Cellerant Therapeutics, Inc. Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Cellerant Therapeutics, Inc. Neutropenia Drugs Product Portfolio Table 85. Cellerant Therapeutics, Inc. Recent Development Table 86. Coherus BioSciences, Inc. Company Information Table 87. Coherus BioSciences, Inc. Business Overview Table 88. Coherus BioSciences, Inc. Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Coherus BioSciences, Inc. Neutropenia Drugs Product Portfolio Table 90. Coherus BioSciences, Inc. Recent Development Table 91. Dr. Reddy’s Laboratories Limited Company Information Table 92. Dr. Reddy’s Laboratories Limited Business Overview Table 93. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Product Portfolio Table 95. Dr. Reddy’s Laboratories Limited Recent Development Table 96. Ligand Pharmaceuticals, Inc. Company Information Table 97. Ligand Pharmaceuticals, Inc. Business Overview Table 98. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Product Portfolio Table 100. Ligand Pharmaceuticals, Inc. Recent Development Table 101. NAL Pharmaceuticals Ltd. Company Information Table 102. NAL Pharmaceuticals Ltd. Business Overview Table 103. NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. NAL Pharmaceuticals Ltd. Neutropenia Drugs Product Portfolio Table 105. NAL Pharmaceuticals Ltd. Recent Development Table 106. Prolong Pharmaceuticals, LLC Company Information Table 107. Prolong Pharmaceuticals, LLC Business Overview Table 108. Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Prolong Pharmaceuticals, LLC Neutropenia Drugs Product Portfolio Table 110. Prolong Pharmaceuticals, LLC Recent Development Table 111. Richter Gedeon Nyrt. Company Information Table 112. Richter Gedeon Nyrt. Business Overview Table 113. Richter Gedeon Nyrt. Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Richter Gedeon Nyrt. Neutropenia Drugs Product Portfolio Table 115. Richter Gedeon Nyrt. Recent Development Table 116. Sandoz International GmbH Company Information Table 117. Sandoz International GmbH Business Overview Table 118. Sandoz International GmbH Neutropenia Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Sandoz International GmbH Neutropenia Drugs Product Portfolio Table 120. Sandoz International GmbH Recent Development Table 121. North America Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. North America Neutropenia Drugs Sales by Country (2021-2026) & (Tons) Table 123. North America Neutropenia Drugs Sales Market Share by Country (2021-2026) Table 124. North America Neutropenia Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 125. North America Neutropenia Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Neutropenia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Neutropenia Drugs Market Share by Country (2021-2026) Table 129. North America Neutropenia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Neutropenia Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Europe Neutropenia Drugs Sales by Country (2021-2026) & (Tons) Table 133. Europe Neutropenia Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Neutropenia Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 135. Europe Neutropenia Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Neutropenia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Neutropenia Drugs Market Share by Country (2021-2026) Table 139. Europe Neutropenia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Neutropenia Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Neutropenia Drugs Sales by Country (2021-2026) & (Tons) Table 143. Asia-Pacific Neutropenia Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Neutropenia Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 145. Asia-Pacific Neutropenia Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Neutropenia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Neutropenia Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Neutropenia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Neutropenia Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Latin America Neutropenia Drugs Sales by Country (2021-2026) & (Tons) Table 153. Latin America Neutropenia Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Neutropenia Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 155. Latin America Neutropenia Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Neutropenia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Neutropenia Drugs Market Share by Country (2021-2026) Table 159. Latin America Neutropenia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Neutropenia Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Neutropenia Drugs Sales by Country (2021-2026) & (Tons) Table 163. Middle East and Africa Neutropenia Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Neutropenia Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 165. Middle East and Africa Neutropenia Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Neutropenia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Neutropenia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Neutropenia Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Neutropenia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Neutropenia Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Neutropenia Drugs Distributors List Table 174. Neutropenia Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Neutropenia Drugs Image Figure 2. Global Neutropenia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neutropenia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Neutropenia Drugs Sales (2021-2032) & (Tons) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (Tons) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Neutropenia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Neutropenia Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Neutropenia Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Neutropenia Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Neutropenia Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Neutropenia Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Neutropenia Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Neutropenia Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Neutropenia Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Neutropenia Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Neutropenia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Neutropenia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Neutropenia Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Tons) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Neutropenia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Neutropenia Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Neutropenia Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Neutropenia Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Neutropenia Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Neutropenia Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Neutropenia Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Neutropenia Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Neutropenia Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Neutropenia Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Neutropenia Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Neutropenia Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Neutropenia Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Neutropenia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Neutropenia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Neutropenia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Neutropenia Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Neutropenia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Neutropenia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Neutropenia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Neutropenia Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Neutropenia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Neutropenia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Neutropenia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Neutropenia Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Neutropenia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Neutropenia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Neutropenia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Neutropenia Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Neutropenia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Neutropenia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Neutropenia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Neutropenia Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Neutropenia Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Injection
Applications
  • Hospital
  • Clinic
Companies covered
  • Apotex Inc.
  • Biogenomics Limited
  • Cellerant Therapeutics, Inc.
  • Coherus BioSciences, Inc.
  • Dr. Reddy’s Laboratories Limited
  • Ligand Pharmaceuticals, Inc.
  • NAL Pharmaceuticals Ltd.
  • Prolong Pharmaceuticals, LLC
  • Richter Gedeon Nyrt.
  • Sandoz International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neutropenia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neutropenia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neutropenia Drugs Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Injection
  8. 1.4 Global Neutropenia Drugs Market Size by Type
  9. 1.4.1 Global Neutropenia Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Neutropenia Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Neutropenia Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Neutropenia Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Neutropenia Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Neutropenia Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Neutropenia Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Neutropenia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neutropenia Drugs Industry Trends
  2. 2.2 Neutropenia Drugs Industry Drivers
  3. 2.3 Neutropenia Drugs Industry Opportunities and Challenges
  4. 2.4 Neutropenia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neutropenia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Neutropenia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Neutropenia Drugs Price (2021-2026)
  4. 3.4 Global Neutropenia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neutropenia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Neutropenia Drugs Company, Product Type & Application
  7. 3.7 Global Neutropenia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neutropenia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neutropenia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neutropenia Drugs Tier 1, Tier 2, and Tier 3
4 Neutropenia Drugs Regional Status and Outlook
  1. 4.1 Global Neutropenia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neutropenia Drugs Historic Market Size by Region
  3. 4.2.1 Global Neutropenia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neutropenia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neutropenia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neutropenia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Neutropenia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neutropenia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neutropenia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neutropenia Drugs by Application
  1. 5.1 Neutropenia Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Neutropenia Drugs Market Size by Application
  5. 5.2.1 Global Neutropenia Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Neutropenia Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Neutropenia Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Neutropenia Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Neutropenia Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Neutropenia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Neutropenia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Neutropenia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Apotex Inc.
  2. 6.1.1 Apotex Inc. Company Information
  3. 6.1.2 Apotex Inc. Business Overview
  4. 6.1.3 Apotex Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Apotex Inc. Neutropenia Drugs Product Portfolio
  6. 6.1.5 Apotex Inc. Recent Developments
  7. 6.2 Biogenomics Limited
  8. 6.2.1 Biogenomics Limited Company Information
  9. 6.2.2 Biogenomics Limited Business Overview
  10. 6.2.3 Biogenomics Limited Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biogenomics Limited Neutropenia Drugs Product Portfolio
  12. 6.2.5 Biogenomics Limited Recent Developments
  13. 6.3 Cellerant Therapeutics, Inc.
  14. 6.3.1 Cellerant Therapeutics, Inc. Company Information
  15. 6.3.2 Cellerant Therapeutics, Inc. Business Overview
  16. 6.3.3 Cellerant Therapeutics, Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cellerant Therapeutics, Inc. Neutropenia Drugs Product Portfolio
  18. 6.3.5 Cellerant Therapeutics, Inc. Recent Developments
  19. 6.4 Coherus BioSciences, Inc.
  20. 6.4.1 Coherus BioSciences, Inc. Company Information
  21. 6.4.2 Coherus BioSciences, Inc. Business Overview
  22. 6.4.3 Coherus BioSciences, Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Coherus BioSciences, Inc. Neutropenia Drugs Product Portfolio
  24. 6.4.5 Coherus BioSciences, Inc. Recent Developments
  25. 6.5 Dr. Reddy’s Laboratories Limited
  26. 6.5.1 Dr. Reddy’s Laboratories Limited Company Information
  27. 6.5.2 Dr. Reddy’s Laboratories Limited Business Overview
  28. 6.5.3 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Product Portfolio
  30. 6.5.5 Dr. Reddy’s Laboratories Limited Recent Developments
  31. 6.6 Ligand Pharmaceuticals, Inc.
  32. 6.6.1 Ligand Pharmaceuticals, Inc. Company Information
  33. 6.6.2 Ligand Pharmaceuticals, Inc. Business Overview
  34. 6.6.3 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Product Portfolio
  36. 6.6.5 Ligand Pharmaceuticals, Inc. Recent Developments
  37. 6.7 NAL Pharmaceuticals Ltd.
  38. 6.7.1 NAL Pharmaceuticals Ltd. Company Information
  39. 6.7.2 NAL Pharmaceuticals Ltd. Business Overview
  40. 6.7.3 NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NAL Pharmaceuticals Ltd. Neutropenia Drugs Product Portfolio
  42. 6.7.5 NAL Pharmaceuticals Ltd. Recent Developments
  43. 6.8 Prolong Pharmaceuticals, LLC
  44. 6.8.1 Prolong Pharmaceuticals, LLC Company Information
  45. 6.8.2 Prolong Pharmaceuticals, LLC Business Overview
  46. 6.8.3 Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Prolong Pharmaceuticals, LLC Neutropenia Drugs Product Portfolio
  48. 6.8.5 Prolong Pharmaceuticals, LLC Recent Developments
  49. 6.9 Richter Gedeon Nyrt.
  50. 6.9.1 Richter Gedeon Nyrt. Company Information
  51. 6.9.2 Richter Gedeon Nyrt. Business Overview
  52. 6.9.3 Richter Gedeon Nyrt. Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Richter Gedeon Nyrt. Neutropenia Drugs Product Portfolio
  54. 6.9.5 Richter Gedeon Nyrt. Recent Developments
  55. 6.10 Sandoz International GmbH
  56. 6.10.1 Sandoz International GmbH Company Information
  57. 6.10.2 Sandoz International GmbH Business Overview
  58. 6.10.3 Sandoz International GmbH Neutropenia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sandoz International GmbH Neutropenia Drugs Product Portfolio
  60. 6.10.5 Sandoz International GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Neutropenia Drugs Sales by Country
  2. 7.1.1 North America Neutropenia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neutropenia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Neutropenia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neutropenia Drugs Market Size by Country
  6. 7.2.1 North America Neutropenia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neutropenia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Neutropenia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neutropenia Drugs Sales by Country
  2. 8.1.1 Europe Neutropenia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neutropenia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Neutropenia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neutropenia Drugs Market Size by Country
  6. 8.2.1 Europe Neutropenia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neutropenia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neutropenia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neutropenia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Neutropenia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neutropenia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neutropenia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neutropenia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Neutropenia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neutropenia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neutropenia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neutropenia Drugs Sales by Country
  2. 10.1.1 South America Neutropenia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neutropenia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Neutropenia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neutropenia Drugs Market Size by Country
  6. 10.2.1 South America Neutropenia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neutropenia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Neutropenia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neutropenia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Neutropenia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neutropenia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neutropenia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neutropenia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Neutropenia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neutropenia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neutropenia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neutropenia Drugs Value Chain Analysis
  2. 12.1.1 Neutropenia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neutropenia Drugs Production Mode & Process
  7. 12.2 Neutropenia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neutropenia Drugs Distributors
  10. 12.2.3 Neutropenia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst